| |
| |
|
| Insider
Information: |
Lewis Joel |
| Relationship: |
|
| City: |
Norcross |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
897,012 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$2,762,797 |
|
|
|
Indirect Value
|
$6,160 |
|
|
| Total
Shares |
899,012 |
|
|
| Total
Value |
$2,768,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-12-30 |
4 |
A |
$1.13 |
$17,500 |
D/D |
15,487 |
698,867 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-01-13 |
4 |
A |
$1.14 |
$17,500 |
D/D |
15,351 |
714,218 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-12-15 |
4 |
A |
$1.16 |
$17,500 |
D/D |
15,086 |
683,380 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$1.16 |
$17,500 |
D/D |
15,086 |
729,304 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-11-15 |
4 |
A |
$1.24 |
$17,500 |
D/D |
14,113 |
654,514 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-11-30 |
4 |
A |
$1.27 |
$17,501 |
D/D |
13,780 |
668,294 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-05-31 |
4 |
A |
$1.29 |
$17,500 |
D/D |
13,566 |
506,651 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-06-15 |
4 |
A |
$1.29 |
$17,776 |
D/D |
13,780 |
520,431 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-06-30 |
4 |
A |
$1.31 |
$17,500 |
D/D |
13,359 |
533,790 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-05-13 |
4 |
A |
$1.36 |
$17,500 |
D/D |
12,868 |
493,085 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-10-31 |
4 |
A |
$1.38 |
$17,500 |
D/D |
12,681 |
640,401 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-07 |
4 |
A |
$1.43 |
$205,685 |
D/D |
143,836 |
873,140 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-15 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
886,520 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-06-30 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
911 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-06-15 |
4 |
A |
$1.46 |
$19,266 |
D/D |
13,196 |
897,362 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-07-31 |
4 |
A |
$1.50 |
$19,266 |
D/D |
12,844 |
935,406 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-16 |
4 |
B |
$1.52 |
$1,520 |
I/I |
1,000 |
1,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-04-29 |
4 |
A |
$1.55 |
$17,500 |
D/D |
11,290 |
480,217 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-05-31 |
4 |
A |
$1.57 |
$19,267 |
D/D |
12,272 |
884,166 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-08-15 |
4 |
A |
$1.60 |
$19,267 |
D/D |
12,042 |
947,448 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-12-15 |
4 |
A |
$1.60 |
$19,267 |
D/D |
12,042 |
1,030,694 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-03-31 |
4 |
A |
$1.61 |
$17,501 |
D/D |
10,870 |
458,870 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-10-14 |
4 |
A |
$1.62 |
$17,499 |
D/D |
10,802 |
627,720 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-09-30 |
4/A |
A |
$1.63 |
$17,500 |
D/D |
10,736 |
616,918 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-07-14 |
4 |
A |
$1.63 |
$19,267 |
D/D |
11,820 |
922,562 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
